José María Mato, Óscar Millet and Joaquín Castilla present their research on Porphyria and Prion diseases, and how ATLAS molecular pharma is a clear example of translational biomedical research. Related info:
Drugs against rare diseases
Related Posts
-
CIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases GalleryCIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases
